The first outbreak of Shiga--toxin producing *Escherichia coli* (STEC) O55:H7 in the United Kingdom occurred in the county of Dorset, England, in July 2014 ([@R1]). Ultimately, 31 cases were linked to the outbreak, and 13 (42%) of those patients had hemolytic uremic syndrome (HUS). Of the 13 with HUS, 8 (66%) had neurologic complications and 11 (90%) required prolonged treatment for kidney replacement. After enhanced epidemiologic surveillance and analysis of the patients' food, exposure, and travel histories, the only epidemiologic link identified was living in or having close links to Dorset County. Extensive microbiological investigations included testing of the environment, nondomestic animals, and household pets. Although no causal link was established, whole-genome sequencing and epidemiologic analyses were indicative of a local endemic zoonotic source ([@R1]).

Previous studies postulated that the common STEC O157:H7 clone evolved from enteropathogenic *E. coli* (EPEC) serotype O55:H7 ([@R2],[@R3]). Evolutionary models predict the stepwise acquisition of a Shiga toxin (Stx)--encoding bacteriophage in the EPEC O55:H7 progenitor strain, followed by the substitution of the *rfb* locus encoding the somatic O55 antigen with that encoding the O157 antigen, the acquisition of the pO157 plasmid, loss of the ability to ferment sorbitol, and loss of the ability to produce β-glucuronidase ([@R3]--[@R6]). Analyses from more recent studies have indicated that the Stx-encoding phage is an unstable evolutionary marker, with frequent acquisition and loss occurring in STEC O55:H7 and all 3 lineages of STEC O157 throughout their evolutionary history ([@R7],[@R8]).

STEC O157:H7 has multiple genetic and phenotypic features that contribute to its pathogenicity or are used for detection and identification. The primary virulence factor defining the STEC group is production of Stx1, Stx2, or both. The genes encoding the toxins, *stx1* and *stx2*, are harbored on lambdoid prophage and are the targets of commercial and in-house diagnostic PCR assays ([@R9]). Both toxins can be divided into several subtypes, Stx1a--1d and Stx2a--2g ([@R10]). The locus of enterocyte effacement (LEE) is a 35-kb pathogenicity island encoding a type III secretion system (T3SS) responsible for the attaching and effacing phenotype that facilitates successful colonization of the human gut ([@R11]). The inability to ferment sorbitol or to produce β-glucuronidase differentiates STEC O157 from ≈90% of other gastrointestinal bacteria ([@R5],[@R12]). These characteristics, along with resistance to tellurite, facilitate the detection and identification of STEC O157:H7 on selective media. The pO157 plasmid encodes multiple putative virulence factors, including enterohemolysin (*ehxA*) and an adhesin (*toxB*) ([@R13]).

The STEC O55:H7 Dorset outbreak strain shared certain characteristics with the STEC O157:H7 clone. Initial PCRs detected the presence of *stx2* and the intimin gene *eae*, a marker for *E. coli* attaching and effacing phenotype; non--sorbitol-fermenting colonies of STEC O55 were identified after culture on sorbitol MacConkey agar ([@R1],[@R9]). However, unlike the STEC O157 clone, the STEC O55 Dorset outbreak strain exhibited β-glucuronidase activity and was sensitive to tellurite. Laboratory records held at the Gastrointestinal Bacterial Reference Unit of Public Health England showed that this highly pathogenic strain had not previously been isolated from humans or animals in the United Kingdom. Our goal with this study was to identify the genetic determinants responsible for the phenotypic characteristics of the STEC O55:H7 Dorset outbreak strain and to explore the strain's evolutionary history.

Materials and Methods
=====================

Bacterial Strains
-----------------

We studied 26 isolates of STEC O55:H7 from the outbreak, 10 isolates of STEC O55:H7 from Ireland, and 79 isolates selected to represent of the broad phylogeny of STEC O157:H7 ([Technical Appendix](#SD1){ref-type="local-data"} Table). From public databases, we retrieved 10 genome sequences for *E. coli* O55:H7 and 2 for STEC O157:H7 ([@R6],[@R7],[@R14],[@R15]) ([Table 1](#T1){ref-type="table"}).

###### *Escherichia coli* O55:H7 genome sequences retrieved from publicly available databases\*

  Name          Accession no.     Serotype   STX            SOR   GUD   Reference
  ------------- ----------------- ---------- -------------- ----- ----- ------------
  USDA 5905     SRS702210         O55        --             \+    \+    ([@R7])
  3256--97--1   AEUA01000000      O55        --             \+    \+    ([@R7])
  RM12579--1    CP003109          O55        --             \+    \+    ([@R7])
  CB9615        NC_013941         O55        --             \+    \+    ([@R10])
  ZH-1141       Pending           O55:H7     --             \+    \+    ([@R14])
  2013C-4465    GCA_001644745.1   O55        Stx1a          \+    \+    ([@R15])
  Sakai                           O157:H7    Stx1a and 2a   --    --    ([@R16])
  155           CP018237          O157:H7    Stx2a          --    --    ([@R17])
  TL-000142     ERR180875         O55        --             \+    \+    This study
  SRR3578942    SRR3578942        O55:H7     Stx2d          \+    \+    This study
  TL-000132     ERR197199         O55        --             \+    \+    This study
  3041--1_85    ERR197201         O55        --             \+    \+    This study
  100446        ERR178176         O55:H7     --             \+    \+    This study

\*GUD, β-glucuronidase; SOR, sorbitol; Stx, Shiga toxin; --, negative; +, positive.

Whole-Genome Sequencing, Assembly, and Alignment
------------------------------------------------

We sequenced all isolates by using an Illumina paired-end (100-bp) protocol ([https://www.illumina.com](https://www.illumina.com/)) and assembled them by using SPAdes Genome Assembler version 3.1.1 ([@R18]). The assemblies were annotated by using Prokka version 1.0.1 ([@R19]). We used the MinION (<https://nanoporetech.com/products/minion>) nanopore platform to sequence an isolate from the outbreak, designated 122262. A hybrid Illumina/MinION de novo assembly of 122262 constructed by using SPAdes yielded 15 contigs with the largest contig spanning the first 2.4 mbp. We aligned published reference genomes against the outbreak reference strain 122262 by using Mauve ([@R20]).

Genome, Plasmid, and Bacteriophage Comparisons
----------------------------------------------

We retrieved from GenBank published nucleotide sequences of key virulence genes associated with toxicity, host-cell adhesion, and metabolic activity and concatenated in FASTA (<http://www.ebi.ac.uk/Tools/sss/fasta/>) file format. To determine the presence and absence of the gene panel, we performed a blastn ([@R21]) comparison against the extracted coding sequences of 122262. Significant hits were defined as those with a nucleotide identity of [\>]{.ul}90% over at least 90% of the query sequence. Truncated sequences were defined as matches with \<90% coverage. We uploaded assembled data from the strains in FASTA file format to the PHAge Search Tool (PHAST) web server for prophage identification ([@R22]). Prophage region detection, prophage annotation, and circular genomic views from PHAST results were used along blast ring image generator (BRIG) plots ([@R23]) to isolate the prophage regions of 122262 and nucleotide homologies to the prophages in the Sakai reference genome ([@R16]). BRIG was used to visually compare the similarities between the Sakai and outbreak strain prophages. We compared prophage regions of 122262 with those extracted and analyzed by Shaaban et al. ([@R17]) by using the pipeline and strains presented in their study.

Phylogenetic Analyses
---------------------

Short reads were quality trimmed ([@R24]) and mapped to the STEC O157:H7 Sakai reference genome (GenBank accession no. BA000007) by using Burrows-Wheeler aligner--maximal exact matching ([@R25]). We sorted and indexed the sequence alignment map output from the Burrows-Wheeler aligner to produce a binary alignment map by using SAMtools ([@R25]). GATK2 ([@R26]) was used to create a variant call format file from each of the B binary alignment maps, which were further parsed to extract only single-nucleotide polymorphism (SNP) positions that were of high quality (mapping quality \>30, coverage of reads that passed quality metrics \>10, variant ratio \>0.9). We used pseudosequences of polymorphic positions to create maximum-likelihood trees by using RAxML ([@R27]). FASTQ (<https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2847217/>) sequences were deposited in the National Center for Biotechnology Information Short Read Archive under the BioProject PRJNA248042.

Results
=======

General Genomic Features
------------------------

STEC O55:H7 strain 122262 had a 5,364,131-bp chromosome and a 67,247-bp single plasmid of replicon type FIB-15. Use of blastn to compare the extracted plasmid sequence from 122262 with publicly available plasmid sequences belonging to CB9615, 2013C-4465, and Sakai indicated that the plasmid of 122262 was 99% identical to pO55 CB9615 over its complete length. Unlike pO157 in STEC O157:H7, the O55:H7 plasmids did not encode toxin B (*toxB*) or the enterohemolysin operon (*ehxABCD*). The *E. coli* O55:H7 strains 122262, CB9615, and 2013C-4465 did, however, encode a remote *toxB* homologue *efa1*/*lifA* on the chromosome that has 29% nt identity (97% coverage) with pO157 *toxB.* The LEE was inserted into the chromosome of strain 122262 at *tRNA-selC*, the most common insertion site in a range of pathogenic *E. coli* chromosomal backgrounds ([@R28]). Antimicrobial drug resistance determinants included *aadA-1b* encoding resistance to streptomycin and *dfrA-1* encoding resistance to trimethoprim.

Prophage Composition of 122262
------------------------------

PHAST identified 15 prophage interruptions in 122262, of which 5 were homologous in nucleotide identity to Sp2, Sp3, Sp6, Sp8, and Sp14 found in Sakai ([@R16]) ([Table 2](#T2){ref-type="table"}; [Figure 1](#F1){ref-type="fig"}). Unique genetic content and position was found for 9 putative prophages ([Figure 1](#F1){ref-type="fig"}). In addition, a Stx2a-encoding phage was identified at the Stx-associated bacteriophage insertion site *yecE* in strain 122262. In Sakai, the Stx1a (Sp15) and Stx2a (Sp5) encoding phages are inserted at *wrbA* and *yehV*, respectively. However, *yecE* is a known Stx-associated bacteriophage insertion site in strains of STEC O157:H7 encoding *stx2a* belonging to lineage Ic ([@R29]).

###### Location of prophages in Shiga toxin--producing *Escherichia coli* O55:H7 isolate 122262 from outbreak in Dorset County, England, July 2014, and related Sakai reference prophage\*

  Prophage in 122262   Location           Related Sakai phage   Identity, %
  -------------------- ------------------ --------------------- -------------
  P1                   298714--355267     Sp8                   96
  P2                   2728769--2738381   NP                    NA
  P3                   2958215--2992979   Sp3                   98
  P4                   3119806--3151485   NP                    NA
  P5                   3702030--3736837   Sp5                   99
  P6                   4031314--4075190   NP                    NA
  P7                   4166735--4223146   NP                    NA
  P8                   4361295--4432383   Sp6                   97
  P9                   4549353--4575262   NP                    NA
  P10                  4662955--4712352   NP                    NA
  P11                  4744636--4768829   NP                    NA
  P12                  4868835--4901248   NP                    NA
  P13                  5136256--5154117   NP                    NA
  P14                  5221278--5261127   Sp14                  98
  P15                  5287889--5361495   NP                    NA
  Stx-encoding phage   3607500--3655000   NP                    NA

\*NA, not applicable; NP, not present; Stx, Shiga toxin.

![BLAST ring image generator (BRIG) plot generated from BLAST+ ([@R21]) comparisons of Shiga toxin--producing *Escherichia coli* (STEC) O55:H7 122262 prophages and homologous STEC O157:H7 Sakai prophages. STEC O55:H7 122262 chromosome is set as the reference genome, and the 122262 prophages (P1--P15) comprise the first ring. The homologous STEC O157:H7 Sakai prophages (Sp2, Sp3, Sp6, Sp8, and Sp14) identified in the BLAST analysis were added to the image according to their known locations ([Table 2](#T2){ref-type="table"}). Putative prophage sequence data were retrieved content from PHAge Search Tool ([@R22]) and plotted in BRIG.](17-0628-F1){#F1}

Long-read sequencing of 122262 facilitated comparison of the sequence of the Stx2a-encoding phage with other publicly available sequences of Stx2a-encoding phage. Shaaban et al. ([@R17]) compared prophage sequences for 14 strains of STEC O157:H7, including 8 Stx2a-encoding phages. Of the 8 Stx2a phages described in that study, 7 were closely related despite being found in globally distributed strains from different lineages. The sequence of the Stx2a-encoding phage from the outbreak strain, 122262, showed most similarity (\>98% nt identity and \>94% sequence coverage over the complete phage) with an outlier Stx2a-encoding phage designated 155, found in a subset of isolates of STEC O157 phage type 32 in lineage 1c, geographically associated with the island of Ireland ([@R17],[@R29]) ([Figure 2](#F2){ref-type="fig"}). The main difference between the 2 prophages was an insertion sequence element, a common source of prophage variation ([Figure 2](#F2){ref-type="fig"}).

![The sequence of the Stx2a-encoding phage from the July 2014 Dorset County, England, outbreak strain of Shiga toxin--producing *Escherichia* coli O55:H7, designated 122262, showed \>98% nt identity with an outlier Stx2a-encoding phage designated 155, found in a subset of isolates of Shiga toxin--producing *Escherichia coli* O157 geographically associated with the island of Ireland. The main difference between the 2 prophages was an insertion sequence element.](17-0628-F2){#F2}

Sorbitol-Negative Phenotype of 122262
-------------------------------------

Like the common STEC O157:H7 clone, the STEC O55:H7 outbreak strain described in this study was characterized by its inability to ferment sorbitol. *srlA* and *srlE* encode components of a glucitol/sorbitol-specific phosphotransferase system. In STEC O157:H7, the sorbitol-negative phenotype was thought to have resulted from frameshifts in *srlA* and *srlE*, as observed in Sakai and EDL933 ([@R5]). SNP analysis of STEC O55:H7 122262 in our study revealed a non-sense mutation in *srlA* causing truncation of the last 29 aa, which was likely to reduce expression or produce a nonfunctional product. The sorbitol-negative phenotype, although a characteristic of STEC O157:H7, is rare in *E. coli* O55:H7 and has been described for only 1 other strain (RM12506, also referred to as BB2 and C523-03; genome not publicly available) ([@R7],[@R30]).

β-Glucuronidase and Tellurite Phenotypes of 122262
--------------------------------------------------

β-glucuronidase is an inducible enzyme encoded by *uidA* and produced by ≈90% of pathogenic and nonpathogenic *E. coli*. The common STEC O157:H7 clone is a rare exception. The *uidA* loss of function mechanism in STEC O157:H7 was elucidated by Monday et al. ([@R31]) and included 2 frameshift mutations. The STEC O55:H7 outbreak strain 122262 had a β-glucuronidase--positive phenotype, and analysis of the genome by using MAUVE ([@R20]) did not identify any disruptive mutations in *uidA*. No β-glucuronidase--negative strains of *E. coli* O55:H7 have been described. Furthermore, the STEC O55 Dorset outbreak strain 122262 did not contain the *ter* cluster and was phenotypically sensitive to tellurite. As a consequence, it did not propagate when inoculated onto cefixime and tellurite sorbitol MacConkey agar and was not detected by routine culture methods used at the local hospital diagnostic microbiology laboratories in the United Kingdom (<https://www.gov.uk/government/publications/smi-b-30-investigation-of-faecal-specimens-for-enteric-pathogens>).

Phylogenetic Analyses
---------------------

To investigate the evolutionary history of the STEC O55 Dorset outbreak strain, we constructed a core genome phylogeny ([Figure 3](#F3){ref-type="fig"}). The analysis divided the sequences of the isolates in this study according to serotype; all isolates of *E. coli* O55:H7 clustered together on a separate branch of the tree, and all isolates of STEC O157:H7 clustered together on the branch below, regardless of sorbitol/β-glucuronidase phenotype or the presence of *stx* ([Figure 3](#F3){ref-type="fig"}). The phylogenetic analysis of *E. coli* O55:H7 indicated that incorporation of the Stx-encoding prophage has occurred on multiple occasions within the EPEC O55:H7 background, with independent acquisition of *stx1* ([@R15]), *stx2d*, and *stx2a* into EPEC O55:H7. Likewise, multiple acquisition and loss events involving *stx1*, *stx2c, stx2a*, and less commonly *stx2d* have been described for STEC O157:H7 ([@R12],[@R32]).

![Core genome phylogeny illustrating the evolutionary history of the of Shiga toxin--producing *Escherichia coli* (STEC) O55 strain from the July 2014 Dorset County, England, outbreak in the context of STEC O157:H7 lineages I, II, and I/II. Scale bar indicates nucleotide substitutions per site.](17-0628-F3){#F3}

As noted by McFarland et al. ([@R1]), the outbreak strain was closely related to STEC O55:H7 *stx2a* isolates identified in Ireland during 2013--2014 ([Figure 3](#F3){ref-type="fig"}). These 6 isolates from Ireland were \<5 SNPs from the Dorset outbreak strain, indicating that the isolates from Ireland and Dorset County shared a common source ([@R8]). The outbreak strain had lost the ability to ferment sorbitol, which appears to be a recent adaption with all ancestral O55:H7, including those isolated in Ireland in 2012 retaining the ability to ferment sorbitol. A similar relationship exists between the sorbitol-positive and sorbitol-negative STEC O157:H7 phenotypes; the sorbitol-negative phenotype is a more recent adaption from the sorbitol-positive progenitor strain ([Figure 3](#F3){ref-type="fig"}) ([@R3],[@R5]).

The most parsimonious model of evolution of the STEC O55:H7 Dorset outbreak strain was a progenitor EPEC O55:H7 sorbitol-fermenting strain lysogenized by an Stx2a-encoding phage and subsequent loss of the ability to ferment sorbitol. This stepwise model of evolution seems to mirror that seen in the common STEC O157:H7 clone; the acquisition of the STEC pathotype preceded phenotypic modulation.

Discussion
==========

In the United Kingdom, STEC is regarded as a substantial threat to public health, and enhanced surveillance systems are in place ([@R32]). In England, HUS developed in ≈5% of symptomatic STEC O157:H7 patients ([@R33]), notably less than the 42% of patients in whom HUS developed during the STEC O55:H7 outbreak described in this study. The Dorset outbreak strain was closely related to the common STEC O157:H7 clone and shared several characteristics, most notably the presence of phage-encoded *stx2a*. Stx2a is associated with more severe symptoms, including the development of HUS, and it is probably the key virulence factor causing the high proportion of HUS cases in this outbreak ([@R10]). Of additional concern was the inability to detect the outbreak strain at the local hospital level by using the standard microbiology investigation method, cefixime and tellurite sorbitol MacConkey agar, because of this strain's sensitivity to tellurite.

A previously published stepwise evolutionary model showed the acquisition of *stx2* by a strain of EPEC O55:H7, resulting in emergence of a strain of STEC O55:H7, which was β-glucuronidase positive and sorbitol positive, closely related but ancestral to STEC O157:H7, which was β-glucuronidase positive and sorbitol positive ([@R34]). The loss of the sorbitol-positive phenotype in STEC O157:H7 was followed by the loss of β-glucuronidase expression, resulting in the common STEC O157 sorbitol-negative β-glucuronidase--negative clone. The evolutionary history of the Dorset outbreak strain begins with the EPEC O55:H7 progenitor strain described previously ([@R6]) ([Figure 3](#F3){ref-type="fig"}). Subsequent acquisition of an Stx2a-encoding phage was confirmed by detection of STEC O55:H7 β-glucuronidase--positive sorbitol-positive isolates in Ireland in 2012 ([Figure 3](#F3){ref-type="fig"}). The loss of the sorbitol-positive phenotype mirrored the genetic events proposed to have occurred in the evolution of STEC O157, albeit by an alternative mechanism.

The parallel, convergent evolutionary history of STEC O157:H7 and STEC O55:H7 may indicate a common driver in the evolutionary process. Adaptation to a new niche may be accompanied by modification of gene expression because genes no longer required for, or incompatible with, the variation in lifestyle are selectively inactivated by point mutation, insertion, or deletion ([@R35]). Loss of the sorbitol-positive phenotype may coincide with the successful colonization of a new animal host or the ability to transmit more effectively between animal hosts without the need to survive in the environment for long periods ([@R28],[@R36]).

The detection of the STEC O55:H7 sorbitol-negative strain in patients in Ireland before the outbreak in Dorset led to speculation that ruminants (most likely cattle or sheep) on the island of Ireland were the source of the outbreak strain ([@R1]). Transmission between Ireland and Dorset may have occurred via movement of persons, livestock, or a secondary vector such as migratory birds ([@R37]). The finding that the Stx2a-encoding phage has a high level of similarity to Stx2a-encoding phage found in a previously described sublineage of STEC O157 PT32 geographically linked to Ireland may provide further evidence of the origin of this strain ([@R17],[@R29]). Phages from STEC O157 may be exchanged with other phages from serotypes of *E. coli* in the gut of the ruminant host or in the environment. Analysis and comparison of phage sequences to provide clues regarding the origin of a strain of STEC is a novel approach to outbreak investigation; additional studies are required to evaluate the utility of the approach. Further work will be hampered by the lack of available sequences of the Stx-encoding phage and the difficulties with assembling the sequences because of the inability of short-read sequencing to resolve the large number of repetitive and paralogous features characteristic of the prophage.

The STEC O55:H7 Dorset outbreak strain described in this study shared characteristics with the common STEC O157:H7 clone, specifically the acquisition of an Stx2a-encoding phage and the sorbitol-negative phenotype. Key differences between the 2 strains include the *rfb* gene cluster, plasmid content, β-glucuronidase phenotype, and the absence of the *ter* gene cluster in the STEC O55:H7 outbreak strain. Despite these differences, this study provides evidence of parallel, convergent evolution of STEC O157:H7 and STEC O55:H7, involving multiple acquisitions of Stx-encoding phages and loss of the ability to ferment sorbitol. Previous studies have shown a clear association with STEC harboring *stx2a* and progression to HUS ([@R10]). Acquisition of the Stx2a-encoding phage seems to explain the emergence of STEC O157:H7 as a clinically significant pathogen; in contrast to the acquisition of *stx2c*, evidence suggests that after Stx2a-encoding phage is integrated in a population, it tends to be maintained and may be associated with higher excretions levels in cattle ([@R29],[@R36]). As such, the emergence of STEC O55:H7 harboring *stx2a* is of public health concern.

###### Technical Appendix

Genomic analysis of 26 isolates of Shiga toxin--producing *Escherichia coli* (STEC) O55:H7 from the July 2014 outbreak in Dorset County, England; 10 isolates of STEC O55:H7 from Ireland; and 79 isolates representing the broad phylogeny of STEC O157:H7.
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